News Reproductive Medicine in Transition: Debate on Reforming Egg Donation

  • Ethics
  • Oocyte Donation
  • Health Policy
Image of a human egg cell
The ban on egg donation in Germany is under review. A political initiative could open up new options for couples, and experts are calling for legislation to be updated in line with current scientific knowledge.

To fulfil a deeply held desire for children despite infertility, women and couples are increasingly placing their hopes on the achievements of reproductive medicine. In 2024 alone, the German IVF Register reported around 131,800 treatment cycles. In some cases, egg donation might be helpful, yet it is currently not permitted in Germany. This is stipulated by the Embryo Protection Act, which came into force in 1991. “Its legal regulations of this act have not been adapted to the numerous new insights gained by research,” explains Leopoldina Member Professor Dr Claudia Wiesemann.

The medical ethicist and historian Wiesemann played a key role in the 2019 statement “Reproductive medicine in Germany – towards an updated legal framework”. In it, the National Academy of Sciences Leopoldina and the Union of the German Academies of Sciences called for a “new and comprehensive regulation of the requirements, processes and consequences of reproductive medicine” (1, p. 3). One of the academies’ recommendations was clear: “Egg donation, which has been prohibited in Germany up to now, should be permitted.” (1, p. 9).

Recently, German Federal Health Minister Nina Warken (CDU, the Christian Democratic Union) initiated a political effort to partially legalise egg donation, aiming to allow couples access to egg donation treatments within Germany while creating a clearly regulated framework with ethical boundaries. To this end, Warken intends to engage in cross-departmental discussions with her counterparts in the Federal Ministry of Justice and the Federal Ministry for Family Affairs, as well as with coalition parliamentary groups. At its core, the proposal seeks to permit a woman to donate her eggs, which remain “unused” after fertility treatment, to a third party. In this context, Claudia Wiesemann notes: “Germany and Luxembourg are the only European Union countries in which egg donation is still prohibited.” 

Back in 2019, the academies’ joint statement noted that the existing legislation no longer aligns with the current state of science or societal realities. In particular, it is concerning that the Embryo Protection Act itself creates problems, for instance by restricting modern reproductive medical procedures, potentially increasing health risks for both the mother and child. Moreover, it is no longer convincing that egg donation is prohibited in Germany under the Act, while sperm donation is permitted. This unequal treatment was originally justified on the grounds of protecting the child’s welfare and avoiding a “split motherhood,” explains Wiesemann. These arguments, she adds, are no longer persuasive in light of recent research.

Expert on the topic Professor Dr Claudia Wiesemann ▸

  • Philosophy of Science
  • Election year 2021

The legal restrictions mean that many couples with unfulfilled desires for children seek treatment in countries with different legal and medical standards. According to Wiesemann, this creates problems: “In Germany, couples are unable to receive comprehensive advice on the advantages and disadvantages of this step, as such advice is considered aiding a criminal offence. The intended parents do not know how the egg donor is dealt with, as the egg donation often takes place anonymously. Furthermore, the child is thus unable to enforce its basic right to know its origins. Pregnant women who want to give birth in Germany often remain silent about the egg donation due to fear of stigmatisation and thus receive worse care”

For some women, egg donation is the only way to have a child. Wiesemann explains that a significant number of women are unable to produce eggs at an early age, due either to congenital factors such as ovarian malformations or premature menopause. The long-standing director of the Institute for Ethics and History of Medicine at the University Medical Centre Göttingen adds: “With respect to heterosexual couples, the advantage of egg donation compared to adoption is that the intended mother can give birth to the child herself and her partner can be the child’s genetic father.” In the case of lesbian couples, one woman can donate her eggs to the other and thus both have a physical link to the child. However, Wiesemann considers the relaxation planned by Minister Warken insufficient: “If only the donation of superfluous eggs is allowed, then at a purely quantitative level it will not be possible to help the vast majority of couples who have an unfulfilled desire to have children. In addition, these eggs are often of limited use, as they come from infertile women or those already at a more advanced age.”

“Relaxing the ban set out by the Embryo Protection Act is a step in the right direction, but it will only marginally improve care for people with an unfulfilled desire to have children,” says Wiesemann. In contrast, using eggs donated by young women can result in pregnancy rates of up to 50 per cent. She also emphasises an important difference between sperm and egg donation: “In contrast to conventional sperm donation, removing eggs involves medical intervention and places a greater burden on the body,” says Wiesemann. However, numerous international studies have shown that side effects can be significantly reduced through improved hormonal stimulation protocols.

Two high-level commissions of scientific experts, established by Leopoldina1 and the Federal Ministry of Health2, have examined the issue in recent years and concluded that the physical burden on donors and the social consequences for all involved are no longer considered significant. In view of the “numerous new research findings,” Wiesemann concludes that state intervention in the constitutionally guaranteed reproductive autonomy of both donor and recipient is “no longer justified” and would run counter to high-quality treatment according to international standards.

Für die Teillegalisierung sieht Bundesministerin Warken einen „engen geregelten Rahmen“ vor. Klare Grenzen für die Eizellspende finden sich bereits in der Stellungnahme der Akademien wieder. Sie hatten 2019 eine verantwortungsvolle Öffnung mit rechtlichen und ethischen „Leitplanken“ empfohlen, um beispielsweise eine Kommerzialisierung von Eizellspenden zu verhindern. Außerdem sollte eine Empfängerin angemessen über die möglichen Komplikationen einer solchen Schwangerschaft aufgeklärt werden – und selbst nicht älter als etwa 50 Jahre sein, da die gesundheitlichen Risiken für Mutter und Kind mit zunehmendem Alter steigen.

For the partial legalisation, Minister Warken envisions a “strictly regulated framework.” Clear boundaries for egg donation are already reflected in the academies’ 2019 statement, which recommended a responsible opening with legal and ethical “guardrails” to prevent commercialisation of egg donations. In addition, recipients should be properly informed of potential complications and should not be older than around 50, as health risks for both mother and child increase with age.

Sources

(1) German IVF Register (Deutsches IVF-Register e.V.) (2025). Journal of Reproductive Medicine and Endocrinology, 05/2025. Gablitz. www.deutsches-ivf-register.de/perch/resources/dir-annual-2024-english.pdf

(2) German National Academy of Sciences Leopoldina and Union of the German Academies of Sciences (2019). Reproductive medicine in Germany – towards an updated legal framework. Statement. Halle/S. www.leopoldina.org/fileadmin/Migrierte_Daten/Publikationen/Dokumente/2019_Stellungnahme_Fortpflanzungsmedizin_19_en_kurz_web_02.pdf

(3) Commission on Reproductive Self-Determination and Reproductive Medicine, established by the German Federal Ministry of Health, the Ministry of Justice, and the Ministry for Education, Family, Senior Citizens, Women and Youth (2024). Recommendations of Working Group 2 – Options for the Legalization of Egg Donation and Altruistic Surrogacy www.bundesgesundheitsministerium.de/fileadmin/Dateien/3_Downloads/K/Kom-rSF/Abschlussbericht_Kom-rSF.pdf (German only) 
 

The Leopoldina uses cookies

We use cookies on our website. Some of them are necessary (functional cookies), while others are not necessary but help us to improve our online offering and operate it economically.

You can consent to the use of non-essential cookies by clicking on the "Accept all" button or by clicking on individual settings and agreeing to them by clicking on "Accept selection".

You can access these settings at any time and deselect cookies at a later date.

Functional

These cookies are technically necessary in order to provide the following core functionalities of the website:

  • Display of the website
  • Anonymisation of IP addresses within log files
  • Status cookie consent
Comfort

In addition to necessary cookies, we also use cookies to make your use of the website more pleasant. If you accept these cookies, external media will be loaded without your further consent.

Tracking

With the help of statistics cookies, we can better customise the content and services of our website to your interests and needs. For statistics and analyses, we use the product Matomo for statistics and analyses.

External link warning

Die Nutzung dieses Teildienstes erfordert ihre Einwilligung in die Verarbeitung zusätzlicher personenbezogener Daten durch einen selbständigen Verantwortlichen: Matterport Inc., 352 E. Java Drive, Sunnyvale, CA 94089, USA. Es gelten folgende Datenschutzhinweise: https://matterport.com/de/node/44. Mit der Einwilligung durch Klick auf „Ok“ kann auch eine Übermittlung von personenbezogenen Daten in ein Land außerhalb der Europäischen Union erfolgen. Die Einwilligung ist freiwillig. Eine Ablehnung führt zu keinen Nachteilen. Eine erteilte Einwilligung kann jederzeit mit Wirkung für die Zukunft widerrufen werden.

Ich bin damit einverstanden, dass bei Nutzung dieses Teildienstes zusätzliche personenbezogene Daten verarbeitet werden. Dabei verarbeitete Datenkategorien: technische Verbindungsdaten des Serverzugriffs (IP-Adresse, Datum, Uhrzeit, abgefragte Seite, Browser-Informationen), Daten zur Erstellung von Nutzungsstatistiken und Daten über die Nutzung der Website sowie die Protokollierung von Klicks auf einzelne Elemente. Zweck der Verarbeitung: Auslieferung von Inhalten, die von Dritten bereitgestellt werden. Rechtsgrundlage für die Verarbeitung: Ihre Einwilligung nach Art. 6 (1) a DSGVO, Art. 49 DSGVO. Verantwortlicher für die Datenverarbeitung Matterport Inc., 352 E. Java Drive, Sunnyvale, CA 94089, USA. Es gilt die Datenschutzerklärung von Matterport Inc.: https://matterport.com/de/node/44.

Visit page ▸